A research team led by Marcos Vilas Boas Filho and Valber de Albuquerque Pedrosa at São Paulo State University (UNESP) in Botucatu, Brazil, working with colleagues at the same institution, has now demonstrated a compact alternative: an electrochemical immunosensor built on a bioconjugated gold electrode that can generate melatonin-associated signals directly in homogenized kidney, liver, and heart tissue from laboratory rats. Published in Discover Electrochemistry, the study is billed as the first proof-of-concept demonstration of electrochemical immunosensing for melatonin in extrapineal tissue. Rather than seeking the lowest detection limit in the field, the team set out to show that antibody-based molecular recognition could be married to electrochemical transduction in matrices as chemically hostile as tissue homogenates.

The analytical chemistry underlying conventional melatonin measurement is well established. Techniques such as chemiluminescence, fluorometry, ultraviolet–visible spectrophotometry, gas chromatography–mass spectrometry, and high-performance liquid chromatography all deliver robust performance, but they demand multiple instrumental platforms, labor-intensive preparation, and long analysis times. Melatonin’s intrinsic photoreactivity compounds the difficulty, requiring manipulation under light-restricted conditions to prevent degradation. Electrochemical biosensors have emerged as attractive alternatives because of their low detection limits, operational simplicity, and rapid response, and recent years have seen nanostructured platforms achieve impressively low limits of detection in serum, urine, food, and pharmaceutical samples. A paper-based graphite electrode, a molecularly imprinted polymer platform, and a sensor incorporating core–shell Cu@Pt nanoparticles have all reported submicromolar detection. But nearly all of these rely on the direct electrochemical oxidation of melatonin, an approach vulnerable to electrode fouling, matrix interference, and overlapping signals from other electroactive compounds—and none had been applied to extrapineal tissue.

The Brazilian team’s strategy inverts that logic. Instead of oxidizing melatonin directly, they built an indirect sensing architecture in which the hormone is captured by an immobilized antibody, and its presence is read out as a measurable suppression of a redox probe’s current. The fabrication begins with a gold electrode 1.7 millimeters in diameter, onto which a self-assembled monolayer of 11-mercaptoundecanoic acid is formed by gold–sulfur bonding, exposing terminal carboxyl groups. These groups are then activated with the classic EDC/NHS coupling chemistry, generating reactive NHS-esters that covalently link to free amine groups on a polyclonal anti-melatonin antibody during overnight incubation at 4 degrees Celsius. The result is the Au/SAM-MUA/anti-ME interface: a stable, antibody-decorated surface in which every subsequent molecular event translates into an electrical signature.

Characterization of the assembly followed the standard toolbox of electroanalytical science. Cyclic voltammetry using the ferricyanide/ferrocyanide couple as a redox probe showed a progressive decline in peak current as each layer was added, confirming that the growing protein and organic films were hindering electron transfer as designed. Electrochemical impedance spectroscopy told the same story quantitatively: the charge-transfer resistance of the bare gold electrode stood at just 5 kilo-ohms, rising to 13 kilo-ohms after monolayer formation, 29 kilo-ohms after EDC/NHS activation, 30 kilo-ohms after antibody immobilization, and a marked 40 kilo-ohms once melatonin bound to the antibody layer. That final jump, the team notes, is the analytical heart of the device—each melatonin molecule captured at the surface adds insulating mass, physically blocking diffusion of the redox probe and deepening the measurable signal.

With square-wave voltammetry optimized at a frequency of 100 hertz, a step potential of 5 millivolts, and a pulse amplitude of 20 millivolts, the researchers calibrated the sensor against commercial melatonin standards across a linear range of 20 to 120 micromolar. The calibration curve carried a negative slope of –0.0034, exactly what the suppression mechanism predicts: the blank current of 0.59 microamperes fell to 0.18 microamperes at 120 micromolar melatonin. The derived figures of merit were a limit of detection of approximately 4 micromolar, a limit of quantification of 14 micromolar, and a striking electrochemical sensitivity of 250 microamperes per micromolar per square centimeter—among the highest sensitivities reported for any electrochemical melatonin platform, and the second highest overall. Recovery analysis with spiked samples reached 99.8 percent, and the sensor held 96.3 percent of its signal between consecutive measurement days, retaining functional integrity for up to eight days before the biological layer required re-immobilization.

Selectivity testing against common biological interferents revealed both strengths and honest limits. Serotonin, dopamine, and uric acid each shifted the redox signal by only 0.8 to 4.0 percent, well within acceptable tolerances. But ascorbic acid alone produced a 9.5 percent suppression, and a mixture of all interferents together caused an 11 percent deviation—statistically significant and a reminder that nonspecific matrix effects can creep into any antibody-based measurement in complex fluids. The authors attribute this partly to possible conformational changes in the antibody at certain pH values, which may partially expose the underlying electrode surface to blocking by other molecules. They are careful to frame the sensor’s selectivity as demonstrable but not yet definitive under all biological conditions.

The biological application was where the platform earned its novelty claim. Thirty male Wistar rats were divided into a treated group receiving intraperitoneal melatonin at 25 milligrams per kilogram three times weekly for four weeks, and a control group receiving saline. Liver, heart, and kidney samples were harvested, homogenized, and spiked with a known melatonin standard before analysis. Across all three tissues, successive additions of homogenate produced the characteristic progressive suppression of the ferri/ferrocyanide anodic current, and tissues from melatonin-treated animals consistently generated stronger current suppression than control samples. Kidney homogenates produced the greatest effect, followed by heart and liver—a pattern the researchers note aligns with known physiology, since the kidney is central to eliminating melatonin metabolites, the liver metabolizes the hormone via cytochrome P450 enzymes, and cardiac tissue harbors extrapineal melatonin and receptors tied to cardiovascular regulation.

The team is appropriately measured about what the tissue data mean. Because the current-response plots in the homogenates lacked sufficient linearity to derive formal detection limits for those matrices, and because no direct comparison with HPLC or LC–MS/MS was performed, the tissue signals are presented strictly as preliminary, qualitative proof-of-concept responses rather than precise quantifications. Still, the implications are considerable. The work establishes, for the first time, that an antibody-functionalized electrochemical interface can register melatonin-associated differences in kidney, liver, and heart tissue—opening a path toward rapid, point-of-care monitoring of hormone distribution in contexts where chromatography is impractical. The researchers say future work will focus on validating the platform against established chromatographic methods and implementing matrix-matched calibration to sharpen quantitative accuracy, potentially extending the technology to studies of circadian biology, neurodegenerative disease research, and antioxidant therapy monitoring where melatonin’s reach beyond the brain matters most.

The choice of an indirect immunosensing format carries practical implications worth underscoring. Because melatonin itself is not oxidized at the electrode surface, the many electroactive species that populate tissue homogenates—ascorbate, urate, catecholamines—compete far less directly for the analytical signal. The trade-off is kinetic and structural: antibody–antigen binding is slower than a simple electron-transfer event, and the biological recognition layer is inherently fragile, which is why the team found the interface required re-immobilization after roughly eight days of use. Such operational lifetimes are typical of protein-based sensors and represent a genuine engineering constraint for any future field deployment.

The tissue-specific response pattern observed in the rat study also merits interpretation. The strongest suppression in kidney homogenates is consistent with the organ’s role as the principal route of melatonin metabolite excretion, while the hepatic signal reflects cytochrome P450-mediated metabolism, the dominant catabolic pathway for the hormone in mammals. Cardiac tissue, meanwhile, is of particular interest because melatonin receptors expressed in myocardium have been linked to blood pressure regulation and cardioprotection, making a rapid tissue-level assay potentially valuable in cardiovascular research.

Methodologically, the spiking approach used in the proof-of-concept experiments deserves note. By adding a known commercial melatonin standard to each homogenate, the researchers could verify that the antibody layer remained functional even amid the proteins, lipids, and salts of a crude tissue matrix. The absence of a chromatographic cross-check, however, means the absolute endogenous concentrations in treated versus control animals remain unknown. Establishing that correlation, alongside matrix-matched calibration curves, will be the decisive next step in determining whether this bioconjugated gold interface can evolve from a qualitative indicator of melatonin-associated tissue responses into a genuinely quantitative analytical instrument for circadian and biomedical research.

Subject of Research: Development of a bioconjugated gold electrochemical immunosensor for detecting melatonin in extrapineal rat tissues

Article Title: Electrochemical melatonin detection in extrapineal tissue using a bioconjugated sensor

Article References: Filho, M. V. B., Agneis, M. L. G., de Souza, M. C., Gavioli, V. D., de Castro, G. R., Seiva, F. R. F., de Almeida Chuffa, L. G., & de Albuquerque Pedrosa, V. (2026). Electrochemical melatonin detection in extrapineal tissue using a bioconjugated sensor. Discover Electrochemistry, 3(1), Article 75. https://doi.org/10.1007/s44373-026-00162-x

Image Credits: AI Generated

DOI: 10.1007/s44373-026-00162-x

Keywords: melatonin, immunosensor, electrochemistry, biosensor, gold electrode, extrapineal tissue, square-wave voltammetry, electrochemical impedance spectroscopy, Wistar rats, circadian rhythm, antioxidant, tissue homogenate

Browning in plant tissue cultures, especially within Musa spp., manifests as a physiological response triggered primarily by polyphenol oxidase (PPO) activity, leading to the oxidation of phenolic compounds. This biochemical cascade hampers cell viability, compromises morphological stability, and significantly reduces propagation efficiency. Traditional methods to counteract browning, including the use of synthetic antioxidants and frequent subculturing, often incur elevated costs and environmental concerns. The current research addresses this persistent bottleneck through an ingenious natural intervention.

The extraction of bioactive compounds from lime peel—an abundant agricultural byproduct often discarded as waste—represents an eco-friendly and sustainable source of phenolic antioxidants. Lime peel is rich in flavonoids, vitamin C, and limonoids, which collectively exhibit robust antioxidative properties capable of scavenging reactive oxygen species (ROS). However, the direct application of such extracts in tissue cultures suffers from instability, rapid degradation, and inconsistent release kinetics, undermining their protective efficacy against browning.

To tackle these limitations, the study employs a sophisticated encapsulation strategy wherein lime peel extract is immobilized within a biopolymeric matrix composed of alginate and gelatin. Alginate, a polysaccharide derived from brown seaweed, is renowned for its gentle gelation facilitated by divalent cations, biocompatibility, and capacity for controlled release. Gelatin, a denatured collagen derivative, complements alginate by enhancing mechanical strength, biodegradability, and cellular affinity. The synergistic combination of these polymers results in microbeads exhibiting tunable porosity, optimal swelling behavior, and sustained antioxidative agent diffusion.

The microencapsulation process utilizes emulsification coupled with ionotropic gelation, permitting the formation of uniform alginate–gelatin beads with a core laden with lime peel extract. Crucial parameters such as polymer concentration, crosslinker ion density, and drying conditions were meticulously optimized to preserve the bioactivity of the encapsulated extract while ensuring bead integrity in the tissue culture milieu. Characterization techniques including scanning electron microscopy (SEM), Fourier-transform infrared spectroscopy (FTIR), and differential scanning calorimetry (DSC) corroborated the successful biochemical incorporation and physical stability of the microbeads.

Upon integrating these microbeads within Musa spp. tissue culture media, a significant retarding effect on browning was observed. Biochemical assays indicated a marked reduction in PPO activity and oxidative stress markers, correlating with enhanced explant viability. The controlled release mechanism sustained the antioxidative milieu in the culture environment, circumventing the need for repetitive extract supplementation. Morphological assessments revealed improved shoot proliferation rates and healthier tissue morphogenesis compared to control groups lacking encapsulated antioxidants.

This innovative intervention not only advances the understanding of plant tissue culture physiology but also introduces a scalable platform for biostable delivery of natural antioxidants. Encapsulation enhances the shelf-life and bioavailability of lime peel bioactives, aligning perfectly with the principles of green chemistry and sustainable agriculture. Moreover, this methodology can be extrapolated to other recalcitrant crops plagued by browning, potentially revolutionizing large-scale micropropagation protocols.

In addition to immediate biotechnological applications, the research invites further exploration into the mechanistic pathways through which encapsulated phytochemicals modulate enzymatic activities and intracellular redox balances in cultured tissues. Genomic and proteomic studies could unravel how sustained antioxidant presence influences stress-responsive gene expression, cellular metabolism, and epigenetic modifications during in vitro propagation. Such insights would deepen the integration of biomaterial science with plant molecular biology.

Commercial adoption of alginate–gelatin microbeads loaded with lime peel extract could drastically reduce the reliance on synthetic anti-browning agents, thus mitigating potential toxicological risks and reducing input costs. The valorization of citrus peel waste aligns with circular economy models, transforming agro-industrial residues into value-added bioproducts. This holistic approach embodies a shift towards sustainable crop production paradigms in the face of global food security challenges.

Future investigations may focus on scaling the microbead synthesis process to industrial volumes, assessing long-term storage stability, and determining the environmental fate of biodegraded polymers post-application. Additionally, customized release profiles tailored to specific crop species and culture stages could optimize antioxidative efficacy. Potential integration with automated tissue culture systems could further enhance operational efficiency.

This novel encapsulation technology symbolizes a confluence of disciplines—plant biotechnology, polymer science, and natural product chemistry—ushering in a new era of smart biostimulants for plant tissue culture. As global agriculture seeks sustainable intensification, such innovative solutions will be pivotal in ensuring crop health, maximizing yield potentials, and minimizing environmental footprints.

By pioneering the encapsulation of lime peel extract within alginate–gelatin microbeads and demonstrating their capacity to inhibit enzymatic browning in Musa spp. tissue culture, the researchers have set a transformative benchmark. This approach exemplifies how natural resource utilization combined with advanced biomaterials can address longstanding cultivation challenges, paving the way for more resilient and efficient plant propagation technologies.

The study’s implications extend beyond bananas, potentially influencing protocols in other vegetatively propagated crops susceptible to oxidative browning, such as pears, apples, and potatoes. The platform’s adaptability to encapsulate various bioactives opens avenues for customizing functional microbeads for diverse agricultural and horticultural applications, including disease resistance, growth promotion, and stress tolerance.

In conclusion, this research encapsulates a critical step forward in enhancing tissue culture methodologies through natural antioxidants’ microencapsulation. Its contribution is poised to resonate in scientific, industrial, and environmental domains alike, underscoring the synergy between sustainable bioresource management and cutting-edge materials science aimed at securing future food production systems.

Subject of Research:
Encapsulation of lime peel extract in alginate–gelatin microbeads for browning inhibition in Musa spp. tissue culture.

Article Title:
Encapsulation of lime peel extract in alginate–gelatin microbeads and its potential for browning inhibition in Musa spp. tissue culture.

Article References:
Permadi, N., Vasall, P.R.N., Sheelmarevaa, F.A. et al. Encapsulation of lime peel extract in alginate–gelatin microbeads and its potential for browning inhibition in Musa spp. tissue culture. Sci Rep (2026). https://doi.org/10.1038/s41598-026-57037-9

Image Credits:
AI Generated

Skin inflammation, a hallmark of various dermatological disorders ranging from eczema to psoriasis, often involves a convoluted interplay between immune responses and oxidative stress. The excess production of reactive oxygen species disrupts cellular homeostasis, leading to tissue damage and heightened inflammatory signaling pathways. Traditionally, treatments have either focused on suppressing the immune system broadly or attempting to mitigate oxidative damage independently, but both approaches lack precision and can produce significant side effects.

The ingenious aspect of this newly developed nanoplatform lies in its capacity to simultaneously deliver dsRNA, which can modulate gene expression and immune responses, while actively scavenging ROS, thereby neutralizing oxidative stress at the source. This dual-action mechanism provides a synergistic therapeutic impact, reducing inflammation and protecting cellular integrity concurrently. The nanoplatform construction encompasses a biologically compatible matrix that facilitates targeted delivery and controlled release, thereby enhancing treatment specificity and minimizing off-target effects.

Double-stranded RNA molecules are well-known for their roles in antiviral defense mechanisms and gene regulation via RNA interference pathways. In this study, the researchers harnessed synthetic dsRNA sequences tailored to interact with skin immune cells, effectively silencing pro-inflammatory cytokine production and dampening pathological immune activation. The design was optimized to enhance cellular uptake and stability in the oxidative microenvironment typical of inflamed skin, ensuring that dsRNA exerts its regulatory influence without being prematurely degraded.

Parallel to the immunomodulatory function, the nanoplatform integrates advanced ROS scavenging materials, including cerium oxide nanoparticles, known for their catalytic antioxidant properties. These nanoparticles mimic natural enzymes such as superoxide dismutase and catalase, converting harmful superoxide radicals and hydrogen peroxide into less reactive species. By mitigating oxidative damage, the nanoplatform not only prevents cellular injury but also interrupts vicious cycles of inflammation perpetuated by ROS signaling.

The fabrication process of this multifunctional nanoplatform involved meticulous nanoengineering to achieve optimal particle size, surface charge, and stability, which are critical parameters for efficient skin penetration and cellular interaction. Additionally, the surface of the nanomaterial was functionalized with ligands that enhance adhesion to inflamed skin tissues and promote uptake by resident immune cells, such as macrophages and dendritic cells, thereby maximizing the therapeutic payload delivery precisely where it is most needed.

In vitro experiments demonstrated that this nanoplatform effectively suppressed inflammatory markers in cultured skin cells exposed to pro-inflammatory stimuli. Notably, there was a significant reduction in the expression of TNF-α, IL-6, and IL-1β, cytokines that play central roles in the pathophysiology of inflammatory dermatoses. Furthermore, assays confirmed the robust ROS scavenging ability, with treated cells showing markedly decreased oxidative stress levels compared to controls.

Moving into in vivo models, the research team applied the nanoplatform to mice with induced skin inflammation. Results were striking, showing rapid attenuation of erythema, swelling, and histological markers of tissue damage. Importantly, the treatment was well-tolerated, with no observable systemic toxicity or adverse immune reactions, underscoring the biocompatibility and safety profile of the nanoplatform.

Mechanistically, the study elucidated how the dsRNA component acts as a molecular interrupter, blocking nuclear factor-kappa B (NF-κB) signaling pathways central to immune activation in inflamed skin. Concurrently, the ROS scavengers restore redox balance by neutralizing oxidative molecules that would otherwise perpetuate inflammatory cascades and cellular apoptosis. This bifocal therapeutic approach addresses both upstream signaling dysregulation and downstream cellular injury.

The implications of this work extend beyond dermatology. The modular design of the nanoplatform holds promise for treating a range of inflammatory and oxidative stress-related diseases. For instance, its principles could be adapted for pulmonary, neurological, or cardiovascular inflammations characterized by similar pathophysiological processes. By customizing the dsRNA sequences and nanoparticle compositions, the approach could be tailored to various tissue types and disease contexts.

Beyond therapeutic benefits, this nanoplatform provides a valuable tool for probing the complex biology of skin inflammation. It enables researchers to dissect how immune modulation and oxidative stress interact dynamically at the cellular level. This deeper understanding could pave the way for novel diagnostic and prognostic markers, further personalizing and improving treatment regimens.

The study also highlights trends in precision medicine, emphasizing multifunctional therapeutics capable of addressing multifactorial disease pathways simultaneously. Conventional monotherapies often fall short due to the redundancy and complexity of biological networks in inflammation. In contrast, integrating gene regulation with enzymatic ROS neutralization exemplifies a next-generation strategy with higher efficacy and potentially fewer side effects.

Challenges remain, however, in scaling this technology for clinical application. Manufacturing reproducibility, regulatory hurdles, and long-term safety profiles require rigorous evaluation. Nevertheless, the foundational science presented by Cui et al. offers a compelling vision of future inflammatory disease management, where nanotechnology and molecular biology converge to deliver highly targeted, efficacious treatments.

In conclusion, the innovative double-stranded RNA and ROS scavenging nanoplatform embodies a significant advancement in the field of dermatological therapeutics. By addressing inflammation through a dual mechanism that combines gene modulation and oxidative stress neutralization, this work not only advances our understanding of skin immune regulation but also sets the stage for transformative clinical therapies. Continued development and refinement of such multifunctional nanomedicines could revolutionize treatment paradigms for inflammatory diseases worldwide, ushering in a new era of precision and effectiveness.

Subject of Research: Skin inflammation treatment using nanotechnology and molecular biology.

Article Title: Double-stranded RNA and ROS scavenging nanoplatform for modulating skin inflammation.

Article References:
Cui, L., Lu, H., Cai, J. et al. Double-stranded RNA and ROS scavenging nanoplatform for modulating skin inflammation. Nat Commun (2026). https://doi.org/10.1038/s41467-026-72964-x

Image Credits: AI Generated